Adenine base editing of CFTR using receptor targeted nanoparticles restores function to G542X cystic fibrosis airway epithelial cells.
In vitro record. Cellular and molecular life sciences : CMLS, 2025.
- Cell
- 2025
Authorship
Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.
Source: the abstract of PMID 40192756. Checked Verification: Evidence verified by machine against declared source
This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.
Evidence verified by machine against declared source
Key facts
- Design
- Not reported
- System
- Cell
- Scale
- (n = 3) using OdysseyCLx fluorescence data.
- Comparator
- Present
- Journal
- Cellular and molecular life sciences : CMLS
- Year
- 2025
- PMID
- 40192756
- Verification
- Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
- Full-text availability
- Abstract only
Technical summary
Research question
In this study, we explored the hypothesis that delivery of ABE using novel self-assembling receptor targeted lipid nanoparticles (RTN) and conversion of G542X to G542R could lead to a therapeutically functional treatment.
Participants or experimental system
We used an adenine base editor (ABE8e Cas9) and guide RNA (sgRNA)/enhanced green fluorescent protein (EGFP) plasmids encapsulated in receptor targeted nanoparticles (RTN), delivered to Bmi-1 transduced basal human CF airway epithelial cells harbouring the homozygous CFTR G542X variant, to convert the stop codon to G542R, a variant which is amenable to modulator therapy.
Study scale
(n = 3) using OdysseyCLx fluorescence data.
Intervention or exposure
Treatment with ETI was performed 24 h prior to functional assessment with 1 μM VX-445, 3 μM VX-661, and 1 μM VX-770.
Comparator
Treatment with IL-1β was used as a positive control.
Outcomes examined
We assessed editing efficiency of ABE delivered as plasmid DNA also encoding EGFP, by RTN to CFTR G542X homozygous airway epithelial cells.
Key findings
In cells differentiated at air–liquid-interface (ALI), 17% and 52% editing of CFTR G542X increased mRNA abundance.
Not reported in the declared source: Methods, Study design.
Limitations and uncertainty
Not reported in the declared source.
Cite
Cite the study
Adenine base editing of CFTR using receptor targeted nanoparticles restores function to G542X cystic fibrosis airway epithelial cells.
Rose I, Greenwood M, Biggart M et al. Cellular and molecular life sciences : CMLS. 2025. PMID 40192756
The study and its abstract belong to their authors and publisher. Cite them for anything the study found.
Report an error
If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.
The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.
The report form runs in the interactive page. Open this record with scripts enabled to send a report.
Corrections on this record
No correction has been recorded for this record.
Method sheet
No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.